Prescription Clinical MonographPrescription Therapeutic Agent
Verified Evidence Sources: openFDA & NLM MedlinePlus
Lixisenatide Injection
Comprehensive clinical interaction and dietary monograph for Lixisenatide Injection (Lixisenatide Injection).
Generic Active Chemical: Lixisenatide Injection
Brand Formulations:AdlyxinSoliqua (as a combination product containing Insulin Glargine and Lixisenatide)
Kitchen Food, Drink & Dietary Conflicts
Biochemical interactions with common foods, beverages & cooking ingredientsOfficial Patient Dietary Instruction (NLM MedlinePlus)
Be sure to follow all exercise and dietary recommendations made by your doctor or dietitian. It is important to eat a healthy diet.
Unless your physician explicitly directs otherwise, continue your normal balanced diet while taking this medication. Maintain consistent hydration and meal intervals.
Prescription & OTC Drug Interactions (DDI)
Documented pharmacological conflicts & contraindicated co-prescriptionsNo major contraindicated drug classes listed in the basic monograph. Always provide your complete medication list to your prescribing physician.
Dietary Supplements, Herbs & Minerals (DNI)
Interactions with over-the-counter vitamins, minerals, and herbal preparationsNo acute supplement or herb contraindications identified. Notify your healthcare provider of any multi-vitamins or botanicals you take daily.
Chronotherapy & Meal Administration Protocols
Optimal absorption, meal-timing rules & GI tolerability protocolsMulti-Substance Interactive Radar
Taking Lixisenatide Injection alongside daily coffee, supplements, or other medications?
Add all your daily medications, foods (Dairy, Spinach, Coffee, Grapefruit), and botanicals (Ashwagandha, Curcumin, Melatonin) into the SafeStack interactive engine to run full multi-way synergy collision analysis in real time.
Authoritative Clinical Evidence & Regulatory Sources
Data on this clinical monograph is compiled from the U.S. National Library of Medicine (MedlinePlus), openFDA Structured Product Labeling (SPL Section 7 Drug Interactions), the NIH Office of Dietary Supplements (ODS), and Krause and Mahan's Food & Nutrition Care Process.